Attenuation of the progression of adjuvant-induced arthritis by 3-aminobenzamide treatment

International Immunopharmacology

Volumn 19, Issue 1, 2014, Pages 52-59

  Ahmad, Sheikh Fayaz ^a   Attia, Sabry M ^a,b   Zoheir, Khairy M A ^a,c   Ashour, Abdelkader E ^a   Bakheet, Saleh A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Al Azhar University   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

3 Aminobenzamide; Adhesion molecules; Adjuvant induced arthritis; Chemokines; Inflammatory mediators; Poly(ADP ribose) polymerase 1 inhibitor

Indexed keywords

3 AMINOBENZAMIDE; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADJUVANT ARTHRITIS; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE EROSION; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; JOINT CAVITY; JOINT EXAMINATION; JOINT SWELLING; KNEE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS;

3-AMINOBENZAMIDE; ADHESION MOLECULES; ADJUVANT INDUCED ARTHRITIS; CHEMOKINES; INFLAMMATORY MEDIATORS; POLY(ADP-RIBOSE) POLYMERASE-1 INHIBITOR;

ANIMALS; ANKLE JOINT; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; BENZAMIDES; CHEMOKINE CCL2; CHEMOKINE CXCL2; CYTOKINES; FEMALE; FREUND'S ADJUVANT; KNEE JOINT; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; POLY(ADP-RIBOSE) POLYMERASES; RNA, MESSENGER; WRIST JOINT;

EID: 84893199707     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.01.005     Document Type: Article

References (61)

1. S. Shall, and G. de Murcia Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat Res 460 2000 1 15
2. F. Laudisi, M. Sambucci, and C. Pioli Poly (ADP-ribose) polymerase-1 (PARP-1) as immune regulator Endocr Metab Immune Disord Drug Targets 11 2011 326 333
3. F. Moroni, A. Cozzi, and A. Chiarugi et al. Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase Br J Pharmacol 165 2012 1487 1500
4. C. Szabo Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications Pharmacol Res 52 2005 60 71
5. P. Pacher, and C. Szabo Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors Cardiovasc Drug Rev 25 2007 235 260
6. E. Mazzon, L. Dugo, J.H. Li, R. Di Paola, T. Genovese, and A.P. Caputi et al. GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat Biochem Pharmacol 64 2002 327 337
7. P. Bai, and L. Virag Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes FEBS Lett 586 2012 3771 3777
8. I.M. Toller, M. Altmeyer, E. Kohler, M.O. Hottiger, and A. Muller Inhibition of ADP ribosylation prevents and cures helicobacter-induced gastric preneoplasia Cancer Res 70 2010 5912 5922
9. L. Cavone, and A. Chiarugi Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis? Trends Mol Med 18 2012 92 100
10. E. Szabo, I. Kovacs, T. Grune, A. Haczku, and L. Virag PARP-1: a new player in the asthma field? Allergy 66 2011 811 814
11. G.S. Firestein Evolving concepts of rheumatoid arthritis Nature 423 2003 356 361
12. W.P. Arend Physiology of cytokine pathways in rheumatoid arthritis Arthritis Rheum 45 2001 101 106
13. K. Kim, M. Cho, and M. Park et al. Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis Arthritis Res Ther 7 1 2005 R139 R148
14. N. Simpson, P.A. Gatenby, and A. Wilson et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus Arthritis Rheum 62 1 2010 234 244
15. M. Ziolkowska, A. Koc, and G. Luszczykiewicz et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism J Immunol 164 5 2000 2832 2838
16. L.E. Harrington, R.D. Hatton, and P.R. Mangan et al. Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 11 2005 1123 1132
17. H. Park, Z. Li, and X.O. Yang et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat Immunol 6 11 2005 1133 1141
18. N. Simpson, P.A. Gatenby, and A. Wilson et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus Arthritis Rheum 62 1 2010 234 244
19. S. Thornton, L.E. Duwel, G.P. Boivin, Y. Ma, and R. Hirsch Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression Arthritis Rheum 42 6 1999 1109 1118
20. Z. Szekanecz, M.M. Halloran, M.V. Volin, J.M. Woods, R.M. Strieter, and H.G. Kenneth III et al. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis Arthritis Rheum 43 2000 1266 1277
21. Y. Yoshihara, H. Nakamura, K. Obata, H. Yamada, T. Hayakawa, and K. Fujikawa et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis Ann Rheum Dis 59 2001 455 461
22. Q. Xie, and C. Nathan The high-output nitric oxide pathway: role and regulation J Leukoc Biol 56 1994 576 582
23. R. Zamora, Y. Vodovotz, and T.R. Billiar Inducible nitric oxide synthase and inflammatory diseases Mol Med 6 2000 347 373
24. S.H. Lee, E. Soyoola, P. Chanmugam, S. Hart, W. Sun, and H. Zhong et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide J Biol Chem 267 1992 25934 25938
25. L.S. Wilkinson, J.C. Edwards, R.N. Poston, and D.O. Haskard Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium Lab Invest 68 1993 82 88
26. S.F. Ahmad, B. Khan, S. Bani, K.A. Suri, N.K. Satti, and G.N. Qazi Amelioration of adjuvant-induced arthritis by ursolic acid through altered Th1/Th2 cytokine production Pharmacol Res 53 2006 233 240
27. S. Cuzzocrea, B. Zingarelli, E. Gilad, P. Hake, A.L. Salzman, and C. Szabó Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation Eur J Pharmacol 342 1 1998 67 76
28. Y. Stern, A. Salzman, R.T. Cotton, and B. Zingarelli Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against laryngeal injury in rats Am J Respir Crit Care Med 160 5 Pt 1 1999 1743 1749
29. N.S. Jagdish, M. Awatef, and M.A. Zaini Comparison between plethysmometer and micrometer methods to measure acute paw oedema for screening anti-inflammatory activity in mice Inflammopharmacology 12 1 2004 89 94
30. S.F. Ahmad, K.M. Zoheir, H.E. Abdel-Hamied, A.E. Ashour, S.A. Bakheet, and S.M. Attia et al. Grape seed proanthocyanidin extract has potent anti-arthritic effects on collagen-induced arthritis by modifying the T cell balance Int Immunopharmacol 17 1 2013 79 87
31. E. Lubberts, M.I. Koenders, and B. Oppers-Walgreen et al. Treatment with a neutralizing antimurine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion Arthritis Rheum 50 2004 650 659
32. Y. Yoshihara, H. Nakamura, K. Obata, H. Yamada, T. Hayakawa, and K. Fujikawa et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis Ann Rheum Dis 59 2000 455 461
33. B. Zingarelli, A.L. Salzman, and C. Szabo Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury Circ Res 83 1998 85 94
34. M.J.L. Eliasson, K. Sampei, A.S. Mandir, P.D. Hurn, R.J. Traystman, and J. Bao et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia Nat Med 3 1997 1090 1095
35. C. Szabó Role of poly(ADP-ribose) synthetase in inflammation Eur J Pharmacol 350 1 1998 1 19 [29]
36. S. Shall Poly(ADP-ribosylation) - a common control process? Bioessays 24 2002 197 201
37. C. Nirodi, S. NagDas, S.P. Gygi, G. Olson, R. Aebersold, and A. Richmond A role for poly (ADP-ribose) polymerase in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene expression J Biol Chem 276 2001 9366 9374
38. P.O. Hassa, C. Buerki, C. Lombardi, R. Imhof, and M.O. Hottiger Transcriptional coactivation of nuclear factor-kappaB dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1 J Biol Chem 278 2003 45145 45153
39. H. Nakajima, H. Nagaso, N. Kakui, M. Ishikawa, T. Hiranuma, and S. Hoshiko Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-kappaB-dependent gene expression in primary cultured mouse glial cells J Biol Chem 279 2004 42774 42786
40. T.M. Kauppinen, and R.A. Swanson Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death J Immunol 174 2005 2288 2296
41. J.J. Goronzy, and C.M. Weyand Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis Trends Immunol 22 2001 251 255
42. C.L. Kohem, R.I. Brezinschek, H. Wisbey, C. Tortorella, P.E. Lipsky, and N. Oppenheimer-Marks Enrichment of differentiated CD45RBdim, CD27 memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis Arthritis Rheum 39 1996 844 854
43. G. Falgarone, L. Semerano, S. Rullé, and M.C. Boissier Targeting lymphocyte activation to treat rheumatoid arthritis Joint Bone Spine 76 4 2009 327 332
44. J.R. Abreu, A.M. Grabiec, S. Krausz, R. Spijker, T. Burakowski, and W. Maslinski et al. The presumed hyporesponsive behavior of rheumatoid arthritis T lymphocytes can be attributed to spontaneous ex vivo apoptosis rather than defects in T cell receptor signaling J Immunol 183 2009 621 630
45. B. Vandooren, T. Noordenbos, C. Ambarus, S. Krausz, T. Cantaert, and N. Yeremenko et al. Absence of a classically activated macrophage cytokine signature in peripheral spondyloarthritis, including psoriatic arthritis Arthritis Rheum 60 4 2009 966 975
46. G.S. Panayi, J.S. Lanchbury, and G.H. Kingsley The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis Arthritis Rheum 35 1992 729 735
47. Z. Szekanecz, A.E. Koch, S.L. Kunkel, and R.M. Strieter Cytokines in rheumatoid arthritis: potential targets for pharmacological intervention Drugs Aging 12 1998 377 390
48. E.M. Gravallese, and S.R. Goldring Cellular mechanism and the role of cytokines in bone erosions in rheumatoid arthritis Arthritis Rheum 43 2000 2143 2151
49. A.Y. Fan, L. Lao, R.X. Zhang, A.N. Zhou, L.B. Wang, and K.D. Moudgil et al. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on adjuvant-induced arthritis in lewis rats J Ethnopharmacol 101 1-3 2005 104 109
50. X. Cai, H. Zhou, Y.F. Wong, Y. Xie, Z.Q. Liu, and Z.H. Jiang et al. Suppression of the onset and progression of collagen-induced arthritis in rats by QFGJS, a preparation from an anti-arthritic Chinese herbal formula J Ethnopharmacol 110 1 2007 39 48
51. R.N. Maini, and P.C. Taylor Anti-cytokines therapy for rheumatoid arthritis Annu Rev Med 51 2000 207 229
52. B.W. Kirkham, M.N. Lassere, J.P. Edmonds, K.M. Juhasz, P.A. Bird, and C.S. Lee et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort) Arthritis Rheum 54 2006 1122 1131
53. E. Lubberts, L.A. Joosten, B. Oppers, B.L. van den, R.C.J. Coenen-de, and J.K. Kolls et al. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis J Immunol 167 2001 1004 1013
54. W.O. Cooper, R.A. Fava, C.A. Gates, and M.A. Cremer Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta A.S. Townes, Clin Exp Immunol 89(2) 1992 244 250
55. E. Brahn, D.J. Peacock, M.L. Banquerigo, and D.Y. Liu Effects of tumor necrosis factor alpha (TNF-alpha) on collagen arthritis Lymphokine Cytokine Res 11 5 1992 253 256
56. R.O. Williams, M. Feldmann, and R.N. Maini Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis Proc Natl Acad Sci U S A 89 20 1992 9784 9788 [15]
57. S. Sakurada, T. Kato, and T. Okamoto Induction of cytokines and ICAM-1 by pro-inflammatory: induction of cytokines and ICAM-1 by pro-inflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin Intern Immunol 8 1996 1483 1493
58. Sun S-x, Li Y-m, Fang W-r, and P. Cheng et al. Effect and mechanism of AR-6 in experimental rheumatoid arthritis Clin Exp Med 10 2010 113 121
59. R.M. Hembry, M.R. Bagga, J.T. Dingle, P.P. Thomas, and J.J. Reynolds Metalloproteinase production by rabbit articular cartilage: comparison of the effects of interleukin-1 alpha in vitro and in vivo Virchows Arch 425 1994 413 424
60. E.H. Choy, and G.S. Panayi Cytokine pathways and joint inflammation in rheumatoid arthritis N Engl J Med 344 12 2001 907 916
61. P. Conti, M. Reale, R.C. Barbacane, M.L. Castellani, and C. Orso Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee Immunol Lett 80 2002 105 111